Try GOLD - Free
PROSOLV® 730: Directly compressible carrier for lipophilic ingredients
Express Pharma
|November 2025
Nearly 90 % of molecules in the discovery pipeline and 40 % of drugs with market approval are poorly water soluble. Poor aqueous solubility can lead to low bioavailability resulting in insufficient plasma levels. Oil-based preparations of these APIs, as well as oily APIs in general, present challenges in terms of solid dosage form manufacturing. PROSOLV® 730 was designed to provide a solution to the formulation of BCS class II and IV APIs. It enables the formulation of lipidic APIs or API-loaded lipid systems by facilitating the adsorption of oil, creating a free-flowing, compactible system that can be further formulated. PROSOLV® 730 is a co-processed, high-functionality excipient comprising MCC SILICA COPOVIDONE
Nearly 90% of molecules in the discovery pipeline and 40% of drugs with market approval are poorly water soluble.
Poor aqueous solubility can lead to low bioavailability resulting in insufficient plasma levels.
Oil-based preparations of these APIs, as well as oily APIs in general, present challenges in terms of solid dosage form manufacturing.
PROSOLVⓇ 730 was designed to provide a solution to the formulation of BCS class II and IV APIs. It enables the formulation of lipidic APIs or APIloaded lipid systems by facilitating the adsorption of oil, creating a free-flowing, compactible system that can be further formulated.
PROSOLV® 730 is a coprocessed, high-functionality excipient comprising MCC SILICA COPOVIDONE
Specific surface area
PROSOLV 730 presents a 70 plus times greater specific surface area than Microcrystalline Cellulose.
Physical Properties of PROSOLV® 730
- High oil binding capacity
- White, free-flowing powder
- Chemically inert
- Non-soluble
- Excellent compactability
- Enhanced lubrication efficiency
- Improved blending properties
- Over 70 times greater specific surface area than regular Microcrystalline Cellulose (MCC)
- Coprocessed excipient with no chemical bonding between ingredients
This story is from the November 2025 edition of Express Pharma.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Express Pharma
Express Pharma
Standardisation vs customisation in single-use systems for bioprocessing: What do biopharma companies need?
Priyabrata Pattnaik, CEO, Ami Polymer highlights the balance between standardisation and customisation in single - use systems in biopharma manufacturing
5 mins
May 2026
Express Pharma
Ensuring Pharma compliance with testo data measurement technology
Due to the crucial necessity and its direct impact on human health and welfare, Pharma is probably the most important and critical sector among others.
3 mins
May 2026
Express Pharma
China+1 moment for pharma: How India can convert opportunity into long-term contracts
Manish Jain, Director, Naprod Life Sciences explains how India must move beyond cost advantage to lead with reliability, quality, and transparency to reshape global pharma supply chains and position itself as a trusted, long-term partner
3 mins
May 2026
Express Pharma
Beyond scale: Rethinking new frontiers in building excellence
At the Injectable Innovations Conclave 2026, hosted by Express Pharma, industry leaders examined the trends, technologies and strategies shaping the next phase of injectable growth, reports
10 mins
May 2026
Express Pharma
Waters receives CE mark for BD BACTEC FXI Culture System under EU IVDR
Next-generation blood culture system records ~3-hour faster detection time and introduces automated blood volume measurement
2 mins
May 2026
Express Pharma
JNPC: Carrying forward a 20-year old legacy
Billed as India's first bulk drug, chemicals and allied manufacturing parks and one of the most successful public-private partnerships (PPP) in the pharma sector, the Jawaharlal Nehru Pharma City (JNPC), also known as Visakha Pharma City, was set up in February 2005 as a PPP initiative by the Govt of Andhra Pradesh (GoAP) through its nodal agency Andhra Pradesh Industrial Infrastructure Corporation (APIIC) with the Ramky Group on a Build-Own-Operate (BOO) basis for 20 years.
3 mins
May 2026
Express Pharma
Romaco's sustainable blister packaging line at interpack
At this year's interpack, the Romaco Group will present its sustainable Unity 600 high-speed blister packaging line, featuring – for the first time – the PF 75 stretch bander.
6 mins
May 2026
Express Pharma
Even drug-resistant cancer targets can be tackled with the right design strategy
Dr Bajarang Kumbhar, Assistant Professor, Sunandan Divatia School of Science, NMIMS Mumbai, explains how Al-driven computational biology is reshaping CAR-T therapy and highlights how these approaches help cut drug discovery timelines and improve targeted, personalised cancer treatment, in an interaction with Kalyani Sharma
7 mins
May 2026
Express Pharma
Navigating legal and regulatory landscape of GLP-1 drugs in India
GLP-1 drugs are drawing sharp regulatory and legal scrutiny, especially with generics entering post-patent expiry. They emphasise that navigating IP, compliance, and marketing rules is now critical for stakeholders
5 mins
May 2026
Express Pharma
From back office to brain trust: How life sciences GCCs are redefining leadership hiring in India
Sai Gandhi, Partner, Positive Moves points out that life sciences GCCs in India are moving from support roles to driving core innovation and global strategy. In turn, leadership hiring is shifting toward cross-functional, globally savvy leaders who can deliver enterprise-wide impact
4 mins
May 2026
Listen
Translate
Change font size
